Simon Paul Poidevin, born on October 31, 1958, is a retired Australian rugby union player renowned for his illustrious career. Notably, he played a pivotal role in the Wallabies' historic achievements, including the 1980 Bledisloe Cup victory against New Zealand, the 1984 "grand slam" tour of Britain and Ireland, and the 1991 Rugby World Cup triumph. Poidevin, a distinguished captain, stands among a select group of four Australian rugby icons to have secured rugby union's Grand Slam, claimed a series win in New Zealand, and earned a Rugby World Cup title.
Copyright 2023 – Finance News Network
14 Mar 2024 - Delve into the cutting-edge realm of regenerative medicine with Kilian Kelly, CEO of Cynata Therapeutics. Learn how their stem cell innovations are shaping the future of healthcare.
19 Dec 2019 - Renergen Limited (ASX:RLT) CEO Stefano Marani reveals the company's discovery of a 12% helium concentration reserve at the Virginia Gas Project in South Africa.
12 Aug 2024 - Jindalee Lithium Limited (ASX:JLL) CEO Ian Rodger provides an overview of the company, discussing the McDermitt project, progress on the PFS and grant funding.
01 Jun 2020 - OncoSil Medical Limited (ASX:OSL) Managing Director and CEO Daniel Kenny talks about the significance of the company's CE Marking approval for its lead product OncoSil, which helps treat pancreatic, liver and biliary duct cancer.
03 Oct 2023 - Alex Hanly, CEO of Lithium Universe Limited (ASX:LU7), provides an update on the company's projects, discussing progress towards developing the Quebec Lithium Processing Hub.
05 Oct 2022 - Etherstack Limited (ASX:ESK) CEO and Executive Director David Deacon discusses recent agreements with Samsung and Nokia and the outlook for the months ahead.
17 May 2023 - Noble Helium Limited (ASX:NHE) Co-Founder and CEO Justyn Wood discusses the demand for and pricing of helium, the geology of the company's project in Tanzania, plans for helium transport and outlook.
26 Aug 2021 - Chimeric Therapeutics Limited (ASX:CHM) Chief Operating Officer Jennifer Chow talks about the company's licensing of a novel, third-generation CDH17 CAR T cell therapy from the University of Pennsylvania, its recent FDA IND clearance and plans for ongoing growth.
30 Mar 2023 - Veris Limited (ASX:VRS) Managing Director and CEO Dr Michael Shirley provides an introduction to the company, discussing its services, the competitive landscape, revenue breakdown, growth opportunities and strategy.
29 Nov 2023 - Equinox Resources Limited (ASX:EQN) CEO Zac Komur discusses the company's move to apply for a large rare earths tenement in Brazil, and the attractions of the jurisdiction.
